EVH - Evolent Health, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
14.14
-0.85 (-5.70%)
As of 12:47PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close14.99
Open15.06
Bid14.17 x 900
Ask14.18 x 900
Day's Range14.10 - 15.21
52 Week Range13.61 - 29.05
Volume2,217,155
Avg. Volume1,021,286
Market Cap1.162B
Beta (3Y Monthly)1.41
PE Ratio (TTM)N/A
EPS (TTM)-0.64
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.86
Trade prices are not sourced from all markets
  • GlobeNewswire8 days ago

    Report: Developing Opportunities within Coty, Perficient, Evolent Health, The Habit Restaurants, Capital Senior Living, and Quanex Building Products — Future Expectations, Projections Moving into 2019

    NEW YORK, Feb. 12, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • PR Newswire12 days ago

    Evolent Health, Inc. to Release Fourth Quarter and Full Year 2018 Operating Results and Host Conference Call on Tuesday, February 26, 2019

    WASHINGTON , Feb. 8, 2019 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company providing an integrated value-based care platform to the nation's leading provider and payer ...

  • Markit12 days ago

    See what the IHS Markit Score report has to say about Evolent Health Inc.

    Evolent Health Inc NYSE:EVHView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderately high for EVH with between 10 and 15% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 15. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding EVH totaled $2.79 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • True Health New Mexico names new leadership roles
    American City Business Journals2 months ago

    True Health New Mexico names new leadership roles

    True Health New Mexico has announced a new president and other leadership appointments. The company also announced that Dr. Mark Epstein has been appointed as plan president, where he will oversee statewide health plan operation and performance. Epstein was previously chief medical officer for New Mexico Health Connections and True Health New Mexico.

  • Should You Avoid Evolent Health Inc (EVH)?
    Insider Monkey2 months ago

    Should You Avoid Evolent Health Inc (EVH)?

    Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]

  • Zacks2 months ago

    Why Evolent Health (EVH) Isn't Done Growing Earnings Yet

    Evolent Health (EVH) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

  • PR Newswire3 months ago

    Evolent Health to Participate in Upcoming Investor Conference

    WASHINGTON , Dec. 5, 2018 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company providing an integrated value-based care platform to the nation's leading health systems and ...

  • 10 "Strong Buy" Stock Picks You Shouldn't Overlook
    Kiplinger3 months ago

    10 "Strong Buy" Stock Picks You Shouldn't Overlook

    The market may be in turmoil, but there still are some compelling stock picks out there for the savvy buyers willing to dig a little deeper. Amazon.com (AMZN) and Google parent Alphabet (GOOGL) recently posted disappointing third-quarter earnings results, dragging down the rest of the market. It appears Wall Street is checking out of large-cap growth stocks for a moment; perhaps now is time to take a breather from them. We used TipRanks data to identify 10 promising stocks with a "Strong Buy" Street consensus - and what sticks out is how little these companies stick out. While Wall Street likes a few big, blue-chip names you're familiar with, it also is awfully bullish on some under-the-radar companies. Here are 10 stock picks that you may not know, but are definitely worth checking out. Wall Street sees these as stocks to buy right now, garnering a significant percentage of buy ratings over the past three months. We also can get an idea of the growth potential via the average analyst price target. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of EVH earnings conference call or presentation 6-Nov-18 10:00pm GMT

    Q3 2018 Evolent Health Inc Earnings Call

  • Evolent Health (EVH) Reports Q3 Loss, Tops Revenue Estimates
    Zacks3 months ago

    Evolent Health (EVH) Reports Q3 Loss, Tops Revenue Estimates

    Evolent Health (EVH) delivered earnings and revenue surprises of 20.00% and 5.10%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press3 months ago

    Evolent Health: 3Q Earnings Snapshot

    The Arlington, Virginia-based company said it had a loss of 16 cents per share. Losses, adjusted for non-recurring costs and stock option expense, were 4 cents per share. The results surpassed Wall Street ...

  • PR Newswire3 months ago

    Evolent Health and SOMOS IPA Aim to Provide Physician-Driven Medicaid Managed Care through New York Innovator Program

    WASHINGTON and NEW YORK, Nov. 6, 2018 /PRNewswire/ -- Evolent Health, Inc. (EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, and SOMOS IPA today announced that Evolent will support the SOMOS IPA network in its operations as a Value-Based Payment (VBP) Innovator in the New York State Department of Health's Innovator program. As announced by the New York State Department of Health, SOMOS IPA has received a new contracting designation as a Value-Based Payment Innovator.

  • PR Newswire3 months ago

    Evolent Health Announces Third Quarter 2018 Results

    WASHINGTON , Nov. 6, 2018 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, ...

  • PR Newswire4 months ago

    Evolent Health, Inc. Announces Exercise of Option to Purchase Additional Convertible Senior Notes Due 2025

    The notes and any Class A common stock of Evolent Health issuable upon conversion of the notes will not be registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. Evolent Health's Services segment focuses on partnering with leading provider organizations to achieve superior clinical and financial results in value-based care.

  • PR Newswire4 months ago

    Evolent Health, Inc. to Release Third Quarter 2018 Operating Results and Host Conference Call on Tuesday, November 6, 2018

    WASHINGTON , Oct. 23, 2018 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company providing an integrated value-based care platform to the nation's leading health systems and ...

  • PR Newswire4 months ago

    Evolent Health, Inc. Announces Pricing of $150.0 Million of Convertible Senior Notes Due 2025

    WASHINGTON , Oct. 17, 2018 /PRNewswire/ --  Evolent Health, Inc. (NYSE: EVH) , a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ...

  • PR Newswire4 months ago

    Evolent Health, Inc. Announces Proposed Offering of $125.0 Million of Convertible Senior Notes Due 2025

    WASHINGTON, Oct. 16, 2018 /PRNewswire/ -- Evolent Health, Inc. (EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health"), today announced that it intends to offer $125.0 million aggregate principal amount of convertible senior notes due 2025, subject to market and other conditions.  Evolent Health also expects to grant the initial purchasers in the proposed offering an option to purchase up to an additional $18.75 million aggregate principal amount of notes.  The notes are being offered only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The notes and any Class A common stock of Evolent Health issuable upon conversion of the notes will not be registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.